News
05-15-2015, 05:40 AM
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China today reported financial results for the three months ended March 31, 2015.
More... (http://www.news-medical.net/news/20150515/CASI-Pharmaceuticals-reports-net-loss-of-2418-million-for-first-quarter-2015.aspx)
More... (http://www.news-medical.net/news/20150515/CASI-Pharmaceuticals-reports-net-loss-of-2418-million-for-first-quarter-2015.aspx)